Mergers and Innovation: Evidence from the Pharmaceutical Industry

Funded Research Proposal

For this project, we will look at how innovation, measured by phase 3 failures during the FDA approval process, motivates drug companies to acquire competitors and, in doing so, how this subsequent M&A activity affects future successes in the pharmaceutical pipeline.Read More